Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

May 01, 1988; Volume 33,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abel, P W

    1. You have access
      Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.
      K P Minneman, C Han and P W Abel
      Molecular Pharmacology May 1988, 33 (5) 509-514;
  2. Amsterdam, P

    1. You have access
      Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

B

  1. Barnes, P J

    1. You have access
      Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;
  2. Bloomquist, J R

    1. You have access
      Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxin.
      J R Bloomquist and D M Soderlund
      Molecular Pharmacology May 1988, 33 (5) 543-550;
  3. Bolard, J

    1. You have access
      Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;
  4. Borowski, E

    1. You have access
      Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

C

  1. Cox, B M

    1. You have access
      Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
      P S Puttfarcken, L L Werling and B M Cox
      Molecular Pharmacology May 1988, 33 (5) 520-527;
  2. Crooke, S T

    1. You have access
      Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;

F

  1. Farb, D H

    1. You have access
      Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
      D J Roca, G D Schiller and D H Farb
      Molecular Pharmacology May 1988, 33 (5) 481-485;
  2. Frossard, N

    1. You have access
      Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;

G

  1. George, S T

    1. You have access
      Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;
  2. Grandordy, B M

    1. You have access
      Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;
  3. Grunwald, R

    1. You have access
      Interaction of the antifolate antibiotic trimethoprim with phosphatidylcholine membranes: a 13C and 31P nuclear magnetic resonance study.
      G R Painter, R Grunwald and B Roth
      Molecular Pharmacology May 1988, 33 (5) 551-558;
  4. Guengerich, F P

    1. You have access
      Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
      F P Guengerich
      Molecular Pharmacology May 1988, 33 (5) 500-508;

H

  1. Han, C

    1. You have access
      Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.
      K P Minneman, C Han and P W Abel
      Molecular Pharmacology May 1988, 33 (5) 509-514;
  2. Henry-Toulme, N

    1. You have access
      Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

J

  1. Johnson, E F

    1. You have access
      Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
      G E Schwab, J L Raucy and E F Johnson
      Molecular Pharmacology May 1988, 33 (5) 493-499;

K

  1. Keys, C

    1. You have access
      Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

L

  1. Loew, G

    1. You have access
      Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;
  2. London, R E

    1. You have access
      In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 559-566;
    2. You have access
      In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 567-573;

M

  1. Malbon, C C

    1. You have access
      Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;
  2. Minneman, K P

    1. You have access
      Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.
      K P Minneman, C Han and P W Abel
      Molecular Pharmacology May 1988, 33 (5) 509-514;
  3. Mong, S

    1. You have access
      Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;
  4. Moxham, C P

    1. You have access
      Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;

P

  1. Painter, G R

    1. You have access
      Interaction of the antifolate antibiotic trimethoprim with phosphatidylcholine membranes: a 13C and 31P nuclear magnetic resonance study.
      G R Painter, R Grunwald and B Roth
      Molecular Pharmacology May 1988, 33 (5) 551-558;
  2. Payne, P

    1. You have access
      Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;
  3. Perlman, M E

    1. You have access
      In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 559-566;
    2. You have access
      In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 567-573;
  4. Puttfarcken, P S

    1. You have access
      Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
      P S Puttfarcken, L L Werling and B M Cox
      Molecular Pharmacology May 1988, 33 (5) 520-527;

R

  1. Raucy, J L

    1. You have access
      Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
      G E Schwab, J L Raucy and E F Johnson
      Molecular Pharmacology May 1988, 33 (5) 493-499;
  2. Rhoden, K J

    1. You have access
      Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction.
      B M Grandordy, N Frossard, K J Rhoden and P J Barnes
      Molecular Pharmacology May 1988, 33 (5) 515-519;
  3. Roca, D J

    1. You have access
      Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
      D J Roca, G D Schiller and D H Farb
      Molecular Pharmacology May 1988, 33 (5) 481-485;
  4. Ross, E M

    1. You have access
      Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.
      C P Moxham, E M Ross, S T George and C C Malbon
      Molecular Pharmacology May 1988, 33 (5) 486-492;
  5. Roth, B

    1. You have access
      Interaction of the antifolate antibiotic trimethoprim with phosphatidylcholine membranes: a 13C and 31P nuclear magnetic resonance study.
      G R Painter, R Grunwald and B Roth
      Molecular Pharmacology May 1988, 33 (5) 551-558;

S

  1. Schiller, G D

    1. You have access
      Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
      D J Roca, G D Schiller and D H Farb
      Molecular Pharmacology May 1988, 33 (5) 481-485;
  2. Schwab, G E

    1. You have access
      Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
      G E Schwab, J L Raucy and E F Johnson
      Molecular Pharmacology May 1988, 33 (5) 493-499;
  3. Selinsky, B S

    1. You have access
      In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 559-566;
    2. You have access
      In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
      B S Selinsky, M E Perlman and R E London
      Molecular Pharmacology May 1988, 33 (5) 567-573;
  4. Soderlund, D M

    1. You have access
      Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxin.
      J R Bloomquist and D M Soderlund
      Molecular Pharmacology May 1988, 33 (5) 543-550;
  5. Stefanska, B

    1. You have access
      Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
      N Henry-Toulme, B Stefanska, E Borowski and J Bolard
      Molecular Pharmacology May 1988, 33 (5) 574-579;

T

  1. Toll, L

    1. You have access
      Conformational determinants of high affinity delta receptor binding of opioid peptides.
      C Keys, P Payne, P Amsterdam, L Toll and G Loew
      Molecular Pharmacology May 1988, 33 (5) 528-536;

V

  1. Vegesna, R V

    1. You have access
      Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;

W

  1. Werling, L L

    1. You have access
      Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
      P S Puttfarcken, L L Werling and B M Cox
      Molecular Pharmacology May 1988, 33 (5) 520-527;
  2. Wu, H L

    1. You have access
      Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
      R V Vegesna, H L Wu, S Mong and S T Crooke
      Molecular Pharmacology May 1988, 33 (5) 537-542;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 5
1 May 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics